Jeffrey R Vittengl1, Lee Anna Clark2, Michael E Thase3, Robin B Jarrett4. 1. Department of Psychology, Truman State University, United States. Electronic address: vittengl@truman.edu. 2. Department of Psychology, University of Notre Dame, United States. 3. Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, United States. 4. Department of Psychiatry, The University of Texas Southwestern Medical Center, United States. Electronic address: Robin.Jarrett@UTSouthwestern.edu.
Abstract
BACKGROUND: Social-interpersonal dysfunction increases disability in major depressive disorder (MDD). Here we clarified the durability of improvements in social-interpersonal functioning made during acute-phase cognitive therapy (CT), whether continuation CT (C-CT) or fluoxetine (FLX) further improved functioning, and relations of functioning with depressive symptoms and relapse/recurrence. METHOD: Adult outpatients (N=241) with recurrent MDD who responded to acute-phase CT with higher risk of relapse (due to unstable or partial remission) were randomized to 8 months of C-CT, FLX, or pill placebo plus clinical management (PBO) and followed 24 additional months. We analyzed repeated measures of patients' social adjustment, interpersonal problems, dyadic adjustment, depressive symptoms, and major depressive relapse/recurrence. RESULTS: Large improvements in social-interpersonal functioning occurring during acute-phase CT (median d=1.4) were maintained, with many patients (median=66%) scoring in normal ranges for 32 months. Social-interpersonal functioning did not differ significantly among C-CT, FLX, and PBO arms. Beyond concurrently measured residual symptoms, deterioration in social-interpersonal functioning preceded and predicted upticks in depressive symptoms and major depressive relapse/recurrence. LIMITATIONS: Results may not generalize to other patient populations, treatment protocols, or measures of social-interpersonal functioning. Mechanisms of risk connecting poorer social-interpersonal functioning with depression were not studied. CONCLUSIONS: Average improvements in social-interpersonal functioning among higher-risk responders to acute phase CT are durable for 32 months. After acute-phase CT, C-CT or FLX may not further improve social-interpersonal functioning. Among acute-phase CT responders, deteriorating social-interpersonal functioning provides a clear, measurable signal of risk for impending major depressive relapse/recurrence and opportunity for preemptive intervention.
RCT Entities:
BACKGROUND: Social-interpersonal dysfunction increases disability in major depressive disorder (MDD). Here we clarified the durability of improvements in social-interpersonal functioning made during acute-phase cognitive therapy (CT), whether continuation CT (C-CT) or fluoxetine (FLX) further improved functioning, and relations of functioning with depressive symptoms and relapse/recurrence. METHOD: Adult outpatients (N=241) with recurrent MDD who responded to acute-phase CT with higher risk of relapse (due to unstable or partial remission) were randomized to 8 months of C-CT, FLX, or pill placebo plus clinical management (PBO) and followed 24 additional months. We analyzed repeated measures of patients' social adjustment, interpersonal problems, dyadic adjustment, depressive symptoms, and major depressive relapse/recurrence. RESULTS: Large improvements in social-interpersonal functioning occurring during acute-phase CT (median d=1.4) were maintained, with many patients (median=66%) scoring in normal ranges for 32 months. Social-interpersonal functioning did not differ significantly among C-CT, FLX, and PBO arms. Beyond concurrently measured residual symptoms, deterioration in social-interpersonal functioning preceded and predicted upticks in depressive symptoms and major depressive relapse/recurrence. LIMITATIONS: Results may not generalize to other patient populations, treatment protocols, or measures of social-interpersonal functioning. Mechanisms of risk connecting poorer social-interpersonal functioning with depression were not studied. CONCLUSIONS: Average improvements in social-interpersonal functioning among higher-risk responders to acute phase CT are durable for 32 months. After acute-phase CT, C-CT or FLX may not further improve social-interpersonal functioning. Among acute-phase CT responders, deteriorating social-interpersonal functioning provides a clear, measurable signal of risk for impending major depressive relapse/recurrence and opportunity for preemptive intervention.
Authors: Robin B Jarrett; Abu Minhajuddin; Howard Gershenfeld; Edward S Friedman; Michael E Thase Journal: JAMA Psychiatry Date: 2013-11 Impact factor: 21.596
Authors: Lewis L Judd; Hagop S Akiskal; Pamela J Schettler; Jean Endicott; Andrew C Leon; David A Solomon; William Coryell; Jack D Maser; Martin B Keller Journal: Arch Gen Psychiatry Date: 2005-12
Authors: Silvana Borges; Yeh-Fong Chen; Thomas P Laughren; Robert Temple; Hiren D Patel; Paul A David; Mitchell Mathis; Ellis Unger; Peiling Yang; Ni A Khin Journal: J Clin Psychiatry Date: 2014-03 Impact factor: 4.384
Authors: James H Kocsis; Alan Schatzberg; A John Rush; Daniel N Klein; Robert Howland; Leah Gniwesch; Sonia M Davis; Wilma Harrison Journal: Arch Gen Psychiatry Date: 2002-08
Authors: Joseph M Trombello; Jeffrey R Vittengl; Wayne H Denton; Abu Minhajuddin; Michael E Thase; Robin B Jarrett Journal: Behav Ther Date: 2018-12-06
Authors: Jeffrey R Vittengl; Lee Anna Clark; Jasper A J Smits; Michael E Thase; Robin B Jarrett Journal: J Affect Disord Date: 2018-08-25 Impact factor: 4.839
Authors: Margo de Jonge; Claudi L H Bockting; Patricia van Oppen; Henricus L Van; Jaap Peen; Martijn J Kikkert; Jack J M Dekker Journal: PLoS One Date: 2018-11-02 Impact factor: 3.240